Nuclear Medicine/Radiopharmaceuticals Market is is projected to expand at a healthy CAGR of 5.9% by 2023
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018, at a CAGR of 5.9%. Growth in this market is mainly driven by factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. Moreover, the use of radiopharmaceuticals in novel neurological applications...